NDLI: “Attenuated psychotic symptoms syndrome” as a risk syndrome of psychosis, diagnosis in DSM-V: The debate

Please wait, while we are loading the content...

A 6-week, multicentre, randomized controlled clinical trial to evaluate the safety and efficacy of placeboxetine hydrochloride in the treatment of major depressive disorder in an Indian setting

Placeboxetine for major depressive disorder: Researcher, author, reader, and reviewer perspectives on randomized controlled trials

Universal mental health program: An extension of life skills education to promote child mental health

Deliberate self-harm and domestic violence: Some answers needed

Study of menstrual irregularities in patients receiving antipsychotic medications

How prayer works

Lorazepam-induced prolonged apnea after ECT-induced prolonged seizure

The seeds of creativity and the soil of poet Kannadasan

Year: 2010, Volume: 52

Year: 2009, Volume: 51

Year: 2008, Volume: 50

Year: 2007, Volume: 49

Year: 2006, Volume: 48

Year: 2005, Volume: 47

Year: 2004, Volume: 46

Year: 2003, Volume: 45

Year: 2002, Volume: 44

Year: 2001, Volume: 43

Year: 2000, Volume: 42

Year: 1999, Volume: 41

Year: 1998, Volume: 40

Year: 1997, Volume: 39

Year: 1996, Volume: 38

Year: 1995, Volume: 37

Year: 1994, Volume: 36

Year: 1993, Volume: 35

Year: 1992, Volume: 34

Year: 1991, Volume: 33

Year: 1990, Volume: 32

Year: 1989, Volume: 31

Year: 1988, Volume: 30

Year: 1987, Volume: 29

Year: 1986, Volume: 28

Year: 1985, Volume: 27

Year: 1984, Volume: 26

Year: 1983, Volume: 25

Year: 1982, Volume: 24

Year: 1981, Volume: 23

Year: 1980, Volume: 22

“Attenuated psychotic symptoms syndrome” as a risk syndrome of psychosis, diagnosis in DSM-V: The debate

Content Provider	PubMed Central
Author	Shrivastava, Amresh Mcgorry, P. D. Ming, Tsuang Woods, Scott W. Cornblatt, Barbara A. Corcoran, Cheryl Carpenter, William
Copyright Year	2011
Abstract	Schizophrenia is a common disorder, affecting approximately 1 out of every 100 people, with a typical onset during adolescence and early adulthood. The personal and societal costs of schizophrenia are extremely high. Prevention of schizophrenia, would offer substantial benefits to patients, their family members, and the community at large. The prodromal phase of schizophrenia has been recognized since the 19th century. At-risk individuals for psychosis and schizophrenia are the subjects who can provide information for intervention prior to development of frank psychosis. This approach is currently being investigated. The question remains, however, whether it can be a diagnostic category by itself. The proposal for including the risk syndrome is one of the recommendations by the working group on schizophrenia and psychotic disorders for the forthcoming DSM-V. There are differing views in academia regarding this proposal. Prior to becoming fully psychotic, a consistent literature demonstrates that patients generally had suffered from accelerating attenuated symptoms and distress. It is important that the prodromal phase be accurately recognized in order to accomplish the goal of prevention. We can then purposefully engage in early intervention aiming toward prevention. A recent strong resurgent interest in this area stems largely from two developments: First, the identification of the neurobiological deficit processes associated with the severity and chronicity of schizophrenia, and second, the development of reliable criteria for diagnosis. Although the general at-risk construct appears to offer great potential to advance both the treatment and research dealing with psychotic illnesses, it seems premature to many researchers to include the syndrome as an established entity in the text of the new DSM-V. It would be far more appropriate to include this proposed syndrome in the appendix and evaluate the many contemporary issues in future studies. The main issues involved in this discussion are the clinical validity of the syndrome, concern about stigma and unnecessary treatment, and need for responding to patients′ distress in addition to the ethical dilemma. In this review we examine the issue of inclusion of the risk syndrome as a diagnosis.
Related Links	http://dx.doi.org/10.4103/0019-5545.75560
Starting Page	57
File Format	PDF
ISSN	00195545
e-ISSN	19983794
Journal	Indian Journal of Psychiatry
Issue Number	1
Volume Number	53
Language	English
Publisher	Medknow Publications & Media Pvt Ltd
Publisher Date	2011-01-01
Access Restriction	Open
Rights Holder	Medknow Publications & Media Pvt Ltd
Subject Keyword	Psychiatry and Mental health Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Psychiatry and Mental Health

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome

DSM-5 Attenuated Psychosis Syndrome in Adolescents Hospitalized With Non-psychotic Psychiatric Disorders

Should “risk syndrome for psychosis” be includedas a diagnosis in DSM-V?

Diagnostic Concepts in the Context of Clinical High Risk/Attenuated Psychosis Syndrome.

The content of attenuated psychotic symptoms in those at clinical high risk for psychosis

Models Predicting Psychosis in Patients With High Clinical Risk: A Systematic Review

Duration of basic and attenuated-psychotic symptoms in individuals at clinical high risk for psychosis: pattern of symptom onset and effects of duration on functioning and cognition

Whither the attenuated psychosis syndrome?

Attenuated Psychosis Syndrome in DSM-5

“Attenuated psychotic symptoms syndrome” as a risk syndrome of psychosis, diagnosis in DSM-V: The debate

Similar Documents

The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome

DSM-5 Attenuated Psychosis Syndrome in Adolescents Hospitalized With Non-psychotic Psychiatric Disorders

Should “risk syndrome for psychosis” be includedas a diagnosis in DSM-V?

Diagnostic Concepts in the Context of Clinical High Risk/Attenuated Psychosis Syndrome.

The content of attenuated psychotic symptoms in those at clinical high risk for psychosis

Models Predicting Psychosis in Patients With High Clinical Risk: A Systematic Review

Duration of basic and attenuated-psychotic symptoms in individuals at clinical high risk for psychosis: pattern of symptom onset and effects of duration on functioning and cognition

Whither the attenuated psychosis syndrome?

Attenuated Psychosis Syndrome in DSM-5

“Attenuated psychotic symptoms syndrome” as a risk syndrome of psychosis, diagnosis in DSM-V: The debate